These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11857379)

  • 1. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.
    Swinnen JV; Roskams T; Joniau S; Van Poppel H; Oyen R; Baert L; Heyns W; Verhoeven G
    Int J Cancer; 2002 Mar; 98(1):19-22. PubMed ID: 11857379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer.
    Shurbaji MS; Kalbfleisch JH; Thurmond TS
    Hum Pathol; 1996 Sep; 27(9):917-21. PubMed ID: 8816886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
    Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
    J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma.
    Moore S; Knudsen B; True LD; Hawley S; Etzioni R; Wade C; Gifford D; Coleman I; Nelson PS
    Int J Cancer; 2005 Apr; 114(4):563-71. PubMed ID: 15609334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis.
    Esslimani-Sahla M; Thezenas S; Simony-Lafontaine J; Kramar A; Lavaill R; Chalbos D; Rochefort H
    Int J Cancer; 2007 Jan; 120(2):224-9. PubMed ID: 17044016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
    Verhoeven G
    Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
    Rossi S; Graner E; Febbo P; Weinstein L; Bhattacharya N; Onody T; Bubley G; Balk S; Loda M
    Mol Cancer Res; 2003 Aug; 1(10):707-15. PubMed ID: 12939396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression.
    Pizer ES; Pflug BR; Bova GS; Han WF; Udan MS; Nelson JB
    Prostate; 2001 May; 47(2):102-10. PubMed ID: 11340632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
    Qiao S; Tuohimaa P
    FEBS Lett; 2004 Nov; 577(3):451-4. PubMed ID: 15556626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of fatty acid synthase in ovarian neoplasms.
    Alò PL; Visca P; Framarino ML; Botti C; Monaco S; Sebastiani V; Serpieri DE; Di Tondo U
    Oncol Rep; 2000; 7(6):1383-8. PubMed ID: 11032949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
    Gansler TS; Hardman W; Hunt DA; Schaffel S; Hennigar RA
    Hum Pathol; 1997 Jun; 28(6):686-92. PubMed ID: 9191002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
    Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
    Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
    Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
    Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
    Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
    Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
    Vāvere AL; Kridel SJ; Wheeler FB; Lewis JS
    J Nucl Med; 2008 Feb; 49(2):327-34. PubMed ID: 18199615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.